blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0247892

EP0247892 - Triazine salt [Right-click to bookmark this link]
Former [1987/49]Novel triazine salt
[1991/17]
StatusNo opposition filed within time limit
Status updated on  27.02.1992
Database last updated on 19.10.2024
Most recent event   Tooltip27.02.1992No opposition filed within time limitpublished on 15.04.1992 [1992/16]
Applicant(s)For all designated states
THE WELLCOME FOUNDATION LIMITED
Unicorn House 160 Euston Road
London NW1 2BP / GB
[1990/30]
Former [1987/49]For all designated states
THE WELLCOME FOUNDATION LIMITED
Unicorn House 160 Euston Road
London NW1 2BP / GB
Inventor(s)01 / Sawyer, David Alan
The Wellcome Research Laboratories
Langley Court Beckenham Kent / GB
02 / Copp, Frederick Charles
32, Stanley Avenue
Beckenham Kent / GB
[1987/49]
Representative(s)Stott, Michael John, et al
Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue Greenford
Middlesex UB6 0NN / GB
[N/P]
Former [1987/49]Stott, Michael John, et al
The Wellcome Research Laboratories Group Patents & Agreements Langley Court
Beckenham Kent BR3 3BS / GB
Application number, filing date87304776.529.05.1987
[1987/49]
Priority number, dateGB1986001318330.05.1986         Original published format: GB 8613183
[1987/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0247892
Date:02.12.1987
Language:EN
[1987/49]
Type: B1 Patent specification 
No.:EP0247892
Date:24.04.1991
Language:EN
[1991/17]
Search report(s)(Supplementary) European search report - dispatched on:EP27.08.1987
ClassificationIPC:C07D253/06, A61K31/53
[1987/49]
CPC:
C07D253/075 (EP,US); C07D253/06 (KR); A61P25/08 (EP);
C07D253/02 (KR)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1987/49]
TitleGerman:Triazin-Salze[1987/49]
English:Triazine salt[1991/17]
French:Sels de triazine[1987/49]
Former [1987/49]Novel triazine salt
Examination procedure04.06.1987Examination requested  [1987/49]
22.06.1989Despatch of a communication from the examining division (Time limit: M04)
25.08.1989Reply to a communication from the examining division
23.01.1990Despatch of a communication from the examining division (Time limit: M04)
23.04.1990Reply to a communication from the examining division
18.05.1990Despatch of communication of intention to grant (Approval: Yes)
29.10.1990Communication of intention to grant the patent
08.01.1991Fee for grant paid
08.01.1991Fee for publishing/printing paid
Opposition(s)25.01.1992No opposition filed within time limit [1992/16]
Fees paidRenewal fee
10.02.1989Renewal fee patent year 03
10.02.1990Renewal fee patent year 04
02.02.1991Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:SearchEP0024351  [ ] (WELLCOME FOUND [GB]);
 EP0093186  [ ] (RICHARDSON VICKS LTD [GB]);
 EP0142306  [ ] (WELLCOME FOUND [GB])
    [ ] - CHEMICAL ABSTRACTS, vol. 94, no. 20, May 18, 1981, Columbus, Ohio, USA YALCINDAG, O.N. "Microchemical identification of drugs with an amidine group. IV. Hexamidine diisethionate." page 394, column 2, abstract no. 162824q & SCI.PHARM. 1980, 48(4), 391-2
ExaminationEP0021121
    - JOURNAL OF PHARMACEUTICAL SCIENCES, Jan. 1977, vol.66, no. 1, pages 1-19
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.